articleArteriosclerosis Thrombosis and Vascular BiologyApr 14, 2022Closed access

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association

PBP. Barton DuellFKFrancine K. WeltyMMMichael MillerACAlan ChaitGHGmerice Hammond
PubMed
Indexed incrossrefpubmed

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is believed to affect >25% of adults worldwide. Unless specific testing is done to identify NAFLD, the condition is typically silent until advanced and potentially irreversible liver impairment occurs. For this reason, the majority of patients with NAFLD are unaware of having this serious condition. Hepatic complications from NAFLD include nonalcoholic steatohepatitis, hepatic cirrhosis, and hepatocellular carcinoma. In addition to these serious complications, NAFLD is a risk factor for atherosclerotic cardiovascular disease, which is the principal cause of death in patients with NAFLD. Accordingly, the purpose of this scientific…

Citation impact

627
total citations
FWCI
86.19
Percentile
100%
References
157
Citations per year

Authors

10
  • PB
    P. Barton DuellCorresponding
  • FK
    Francine K. Welty
  • MM
    Michael Miller
  • AC
    Alan Chait
  • GH
    Gmerice Hammond

Topics & keywords

Keywords
  • Nonalcoholic fatty liver disease
  • Disease
  • Fatty liver
  • Risk factor
  • Pathophysiology
  • Atherosclerotic cardiovascular disease
  • Statement (logic)
  • Liver disease
No related works found for this paper.